CHCWM – Cancer & Hematology Centers of West Michigan

CC-94676-  (Celgene)

CC-94676-  (Celgene)

Description:  A Phase 1, Multi-Center, Open-Label, Dose Finding Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of CC-94676 In Subjects With Metastatic Castration-Resistant Prostate Cancer

Mechanism of Action:  Oral Androgen Receptor Degrader

Target Patient Population:  Prostate Cancer

Study Design:  Drug is given orally daily.